Vecchiolla Thomas A. 4
4 · Calidi Biotherapeutics, Inc. · Filed Dec 26, 2023
Insider Transaction Report
Form 4
Vecchiolla Thomas A.
Director
Transactions
- Award
Common Stock
2023-12-21$1.80/sh+7,709$13,876→ 365,105 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units ("RSUs") subject to the conditions of the Restricted Stock Unit Award Agreement pursuant to the Issuer's 2023 Plan. Each RSU represents a right to receive one share of the Company's common stock upon vesting. The number of RSUs to be issued will equal to the amount due to the director for Board fees divided by the closing price for a share of the Issuer's common stock on December 21, 2023, of $1.80. The RSUs were granted in a transaction exempt under Rule 16b-3 to the Reporting Person. The shares of common stock underlying the RSUs immediately vested on the grant date.